C07C233/52

N-acylated 1-aminocycloalkyl carboxylic acids as food flavouring compounds

Compounds represented by the formula ##STR00001## and their edible salts, and edible compositions containing same wherein R.sub.1 is an alkyl residue containing 6 to 20 carbon atoms, or an alkene residue containing from 9 to 25 carbon atoms with 1 to 6 double bonds, such that R.sub.1 together with the carbonyl group to which it is attached is a residue of a carboxylic acid, and the amino acid residue connected to the carbonyl carbon atom is a residue of a 1-amino cycloalkane carboxylic acid (ACCA), and n is 1, 2, 3 or 4.

N-acylated 1-aminocycloalkyl carboxylic acids as food flavouring compounds

Compounds represented by the formula ##STR00001## and their edible salts, and edible compositions containing same wherein R.sub.1 is an alkyl residue containing 6 to 20 carbon atoms, or an alkene residue containing from 9 to 25 carbon atoms with 1 to 6 double bonds, such that R.sub.1 together with the carbonyl group to which it is attached is a residue of a carboxylic acid, and the amino acid residue connected to the carbonyl carbon atom is a residue of a 1-amino cycloalkane carboxylic acid (ACCA), and n is 1, 2, 3 or 4.

ANTIVIRAL-AGENT RESISTANT VIRUS DETECTION SYSTEM
20180346417 · 2018-12-06 ·

An oseltamivir analogue and nanoparticles having the analogue bound thereto, of the present invention, strongly bind to oseltamivir-resistant influenza virus, and thus, the use of the same can allow detection of oseltamivir-resistant influenza viruses quickly and conveniently with the naked eye. Therefore, the present invention can be favorably utilized in promptly establishing a therapeutic schedule for a patient infected with influenza viruses.

ANTIVIRAL-AGENT RESISTANT VIRUS DETECTION SYSTEM
20180346417 · 2018-12-06 ·

An oseltamivir analogue and nanoparticles having the analogue bound thereto, of the present invention, strongly bind to oseltamivir-resistant influenza virus, and thus, the use of the same can allow detection of oseltamivir-resistant influenza viruses quickly and conveniently with the naked eye. Therefore, the present invention can be favorably utilized in promptly establishing a therapeutic schedule for a patient infected with influenza viruses.

PROCESS FOR PREPARING SUBSTITUTED CYCLOHEXANE AMINO ACID ESTERS AND SPIROKETAL-SUBSTITUTED CYCLIC KETO-ENOLS

The present invention relates to a novel process for preparing substituted cyclohexane amino acid esters and spiroketal-substituted cyclic keto-enols, and to novel intermediates or starting compounds that are passed through or used in the process according to the invention.

PROCESS FOR PREPARING SUBSTITUTED CYCLOHEXANE AMINO ACID ESTERS AND SPIROKETAL-SUBSTITUTED CYCLIC KETO-ENOLS

The present invention relates to a novel process for preparing substituted cyclohexane amino acid esters and spiroketal-substituted cyclic keto-enols, and to novel intermediates or starting compounds that are passed through or used in the process according to the invention.

POLYMERIZABLE POLAR COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE

Shown is a compound represented by formula (1). For example, R.sup.1 is alkyl having 1 to 15 carbons; MES is a mesogen group having at least one ring; Sp.sup.1 is a single bond or alkylene having 1 to 10 carbons; M.sup.1 is methyl; and R.sup.2, M.sup.2 and M.sup.3 are hydrogen.

##STR00001##

Polymerizable compound, polymer, polymerizable composition, film, and half mirror for displaying projection image

The present invention provides a polymerizable compound denoted by Formula (I): in the formula, Z.sup.1 and Z.sup.2 represent an arylene group, and the like, m represents 1 or 2, n represents an integer of 0 or 1, and when m is 2, n is 0, L.sup.1, L.sup.2, L.sup.3, and L.sup.4 each independently represent a linking group such as C(O)O and OC(O), T.sup.3 represents -Sp.sup.4-R.sup.4, X represents O, and the like, r represents 1 to 4, Sp.sup.1, Sp.sup.2, Sp.sup.3, Sp.sup.4, and Sp.sup.5 each independently represent a single bond or a linking group, R.sup.1 and R.sup.2 each independently represent a polymerizable group, and R.sup.3, R.sup.4, and R.sup.5 each independently represent a hydrogen atom, a polymerizable group, or the like; a polymerizable composition containing the polymerizable compound described above; a film formed of the polymerizable composition described above; and a half mirror for displaying a projection image including the film described above. ##STR00001##

Polymerizable compound, polymer, polymerizable composition, film, and half mirror for displaying projection image

The present invention provides a polymerizable compound denoted by Formula (I): in the formula, Z.sup.1 and Z.sup.2 represent an arylene group, and the like, m represents 1 or 2, n represents an integer of 0 or 1, and when m is 2, n is 0, L.sup.1, L.sup.2, L.sup.3, and L.sup.4 each independently represent a linking group such as C(O)O and OC(O), T.sup.3 represents -Sp.sup.4-R.sup.4, X represents O, and the like, r represents 1 to 4, Sp.sup.1, Sp.sup.2, Sp.sup.3, Sp.sup.4, and Sp.sup.5 each independently represent a single bond or a linking group, R.sup.1 and R.sup.2 each independently represent a polymerizable group, and R.sup.3, R.sup.4, and R.sup.5 each independently represent a hydrogen atom, a polymerizable group, or the like; a polymerizable composition containing the polymerizable compound described above; a film formed of the polymerizable composition described above; and a half mirror for displaying a projection image including the film described above. ##STR00001##

BICYCLIC ANALGESIC COMPOUNDS
20180042871 · 2018-02-15 ·

Analgesic compounds for treatment of pain or fever that include a bicyclopentane moiety linked to an amine, combinations of the compounds with opioid analgesic drugs, and methods for treating pain or fever by administering a compound described herein.